Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. - Wikidata - wikimedia - TriplyDB

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

http://www.wikidata.org/entity/Q27824827

about

NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation Identification of HEXIM1 as a positive regulator of p53 Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell proliferation via incorporation into the PeBoW-complex Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1 Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications Recurring mutations found by sequencing an acute myeloid leukemia genome Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action Nucleophosmin: from structure and function to disease development Molecules that target nucleophosmin for cancer treatment: an update Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia Molecular prognostic factors in cytogenetically normal acute myeloid leukemia New targets for the antitumor activity of gambogic acid in hematologic malignancies Genomics of acute myeloid leukemia DNMT3A Mutations in Acute Myeloid Leukemia CIViC database Structural Consequences of Nucleophosmin Mutations in Acute Myeloid Leukemia Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia Structure of Nucleophosmin DNA-binding Domain and Analysis of Its Complex with a G-quadruplex Sequence from the c-MYC Promoter Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.Roles and regulations of the ETS transcription factor ELF4/MEF Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications Advancing the Minimal Residual Disease Concept in Acute Myeloid Leukemia LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis

P2860

4c59b897e0f8a8967880f77bba4d5df90bbb5bb2

P248

Q21296810-2AD7900F-FA6A-481E-9B02-BDB5B3155919 Q22001531-4952C183-8806-4A06-876B-E52FBAFA1558 Q24297975-0BD619FA-46AA-4D49-BD6F-A1214977496E Q24301836-777AE631-23A5-436E-ABF6-AF2F2DDCE79B Q24304508-C3C1E9D4-D9C1-46EB-B5B0-55E400AE3B81 Q24322997-0F382F79-0C96-469D-917B-CE53012F36BF Q24338388-F6CECA55-1083-494C-A4C0-B5A242BE43EE Q24338634-1CD86A15-9CAB-4774-B36E-B4FF885C4A31 Q24540385-26A0C8D4-79C0-49F8-8D15-D9815C369990 Q24602856-71154F5D-7FCE-484C-8F36-519506E29866 Q24612217-CAB2FA33-9754-4B93-B1B5-84202ED6A602 Q24617091-553FC30F-6CAB-4AB5-9391-0DC0A75A7568 Q24634204-4753BAD3-00AB-4AB9-8C67-5EB2AFD599B4 Q24642177-687311BE-4299-4E3E-B0BA-8B02E8B2DE0D Q24644436-A22504B1-66B9-4BCD-AA7D-798C4C3D400C Q24652323-39B48378-1313-4EB3-BD83-8C429FCAB4ED Q24672548-1DCE90DD-3CCC-45B4-9F31-414BD7CB78DE Q26739704-E60F778B-10D5-4C53-A0F7-8E22C947036C Q26750653-DE47F06C-15FE-4967-8071-4D04C51053C2 Q26776393-3B0CD703-D202-48C8-88E8-56190A480848 Q26796514-715946C7-2AFC-4E76-91EC-BB102D93F0AD Q26998811-FDC62252-D766-49F7-8B71-2BA2219FE9E0 Q27007789-E3342E94-A80D-4539-AE50-B591609A4498 Q27021548-B8246367-7952-492C-AF17-9D40A2208A18 Q27559610-A279008E-3BC0-498A-99F3-2BD3953B65BF Q27612411-F875B256-1B7E-45ED-8198-8E40CD274B03 Q27650716-9C443C0B-E399-4109-932A-5F6EE3BDB8EF Q27674083-4C4018D3-31D7-4F9C-90CB-1A44298785F8 Q27681217-1E7B927A-2F95-4A7A-BFCD-97EBAD5B1F18 Q27712238-A763969D-0707-4FAF-90AF-551DA1E06DF3 Q27851436-A3B1D435-FEE6-483C-BAA2-E5242B853D4D Q27851545-9BD24021-B16E-4790-826B-49FFA5B39A91 Q27851636-D8808C4F-28CA-46D6-8EC8-E63945D08D20 Q27851642-F5B3BD0B-65D1-44E5-B7FD-921ED62C634B Q27851839-13A7FC92-8D6C-4A1D-9B3E-489F4A74A311 Q27853009-5CD3130F-5A23-4001-85B2-678E32E57567 Q28072925-72A017EB-62C8-4CBA-8BD6-0C4F094B7862 Q28073464-8BFD8C2F-D966-4E83-AEAD-51C06CE93B44 Q28087291-12AC2296-59D2-4DD9-8A78-07F0BE373A43 Q28255964-6D52B517-9A64-4095-809A-98C0E553AD35

P2860

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

http://www.wikidata.org/entity/Q27824827

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@ast

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@en

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@nl

type

label

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@ast

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@en

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@nl

prefLabel

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@ast

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@en

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@nl

P1433

Q27824827-0334FA03-B99A-4F7D-AD5C-3ACA0F5689C2

P1476

Q27824827-5B5E0ECC-660C-45B1-9289-BF4C06BDDBF0

P2093

Q27824827-2DF8CD99-0B80-4D92-8DB3-743F01FA7D45

Q27824827-3096F11B-51BB-4E82-89F7-5473DCF4A8ED

Q27824827-3103FF65-2B07-41E9-A573-E8BC44944DF0

Q27824827-3DDC4DF3-CB38-4A1B-8596-0BC82AB876E7

Q27824827-40114C39-E028-4B07-88AE-F648C5B8F387

Q27824827-51B8621F-193F-44C0-BF39-CBEE397C2E0A

Q27824827-5A2E5E7C-CE86-4249-87CE-488FF89B1042

Q27824827-5B2F93D2-C0BD-49B9-AC62-DEF35412BF83

Q27824827-5B975349-81EA-4561-866F-6D1CAEC5C464

Q27824827-5F2ACBBA-F315-4C55-92C5-E75A5C62FE17

P304

Q27824827-C29F230A-1F88-47B7-82E8-94BB5E3468A1

P31

Q27824827-9045BAC9-2720-46E7-8602-7ADF5A58A87B

P3181

Q27824827-D94997DD-9B9F-4EEA-9F1A-B95C98E2C8EB

P356

Q27824827-A855B103-64F4-4528-A151-0621A27C1D3E

P407

Q27824827-BBCE53D4-F2BC-4DA1-9EBA-7020DBBC66AA

P433

Q27824827-01C73698-A5AE-4001-B7BA-F61998501931

P478

Q27824827-68D7F4D2-41BA-4EF6-A5DC-F4C316ADC537

P50

Q27824827-1256437A-1C72-49AB-83F2-1B2CACD037C8

Q27824827-13C8CB5E-3D67-4676-959D-A3F9EC1C832C

Q27824827-37E34AB5-85A7-47E7-9302-B8F22E94C897

Q27824827-8C24F006-67FF-49C4-9663-25EE0E3A3DD7

Q27824827-9B2BF1E0-3DE8-48AA-B086-600DA90E9EAA

Q27824827-CB9647BF-6857-45FA-BB6A-AFE18876B55A

P577

Q27824827-2CC4EF84-35B8-446C-A6A0-DE6493DD0127

P698

Q27824827-2C58FAB1-197E-4B59-9353-84B2C4401772

P921

Q27824827-2A3A9EFD-E621-440A-B63F-B678D6541776

Q27824827-5D24BEC3-CEE1-4B35-A892-C303A0037B14

P3181

P356

P1433

The New England Journal of Medicine

P1476

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

@en

P2093

Alessandra Pucciarini

http://www.w3.org/2001/XMLSchema#string

Antonella Santucci

http://www.w3.org/2001/XMLSchema#string

Arcangelo Liso

http://www.w3.org/2001/XMLSchema#string

Barbara Bigerna

http://www.w3.org/2001/XMLSchema#string

Cristina Mecucci

http://www.w3.org/2001/XMLSchema#string

Daniela Diverio

http://www.w3.org/2001/XMLSchema#string

Emanuela Colombo

http://www.w3.org/2001/XMLSchema#string

Enrico Tiacci

http://www.w3.org/2001/XMLSchema#string

Franco Mandelli

http://www.w3.org/2001/XMLSchema#string

Massimo F Martelli

http://www.w3.org/2001/XMLSchema#string

P304

254-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

455107

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA041974

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Laura Pasqualucci

Giuseppe Saglio

Brunangelo Falini

Francesco Lo-Coco

P577

2005-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15659725

http://www.w3.org/2001/XMLSchema#string

P921